These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37429512)

  • 1. AD-BERT: Using pre-trained language model to predict the progression from mild cognitive impairment to Alzheimer's disease.
    Mao C; Xu J; Rasmussen L; Li Y; Adekkanattu P; Pacheco J; Bonakdarpour B; Vassar R; Shen L; Jiang G; Wang F; Pathak J; Luo Y
    J Biomed Inform; 2023 Aug; 144():104442. PubMed ID: 37429512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classifying the lifestyle status for Alzheimer's disease from clinical notes using deep learning with weak supervision.
    Shen Z; Schutte D; Yi Y; Bompelli A; Yu F; Wang Y; Zhang R
    BMC Med Inform Decis Mak; 2022 Jul; 22(Suppl 1):88. PubMed ID: 35799294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classifying social determinants of health from unstructured electronic health records using deep learning-based natural language processing.
    Han S; Zhang RF; Shi L; Richie R; Liu H; Tseng A; Quan W; Ryan N; Brent D; Tsui FR
    J Biomed Inform; 2022 Mar; 127():103984. PubMed ID: 35007754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech.
    Balagopalan A; Eyre B; Robin J; Rudzicz F; Novikova J
    Front Aging Neurosci; 2021; 13():635945. PubMed ID: 33986655
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.
    Arvidsson I; Strandberg O; Palmqvist S; Stomrud E; Cullen N; Janelidze S; Tideman P; Heyden A; Åström K; Hansson O; Mattsson-Carlgren N
    Alzheimers Res Ther; 2024 Mar; 16(1):61. PubMed ID: 38504336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Glaucoma Progression Requiring Surgery Using Clinical Free-Text Notes and Transfer Learning With Transformers.
    Hu W; Wang SY
    Transl Vis Sci Technol; 2022 Mar; 11(3):37. PubMed ID: 35353148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating predictors of progression from mild cognitive impairment to Alzheimer's disease based on different time intervals.
    Wu Y; Wang X; Gu C; Zhu J; Fang Y
    Age Ageing; 2023 Sep; 52(9):. PubMed ID: 37740920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Deep Learning Model for Earlier Detection of Cognitive Decline From Clinical Notes in Electronic Health Records.
    Wang L; Laurentiev J; Yang J; Lo YC; Amariglio RE; Blacker D; Sperling RA; Marshall GA; Zhou L
    JAMA Netw Open; 2021 Nov; 4(11):e2135174. PubMed ID: 34792589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a machine learning model to predict mild cognitive impairment using natural language processing in the absence of screening.
    Penfold RB; Carrell DS; Cronkite DJ; Pabiniak C; Dodd T; Glass AM; Johnson E; Thompson E; Arrighi HM; Stang PE
    BMC Med Inform Decis Mak; 2022 May; 22(1):129. PubMed ID: 35549702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.
    Moradi E; Pepe A; Gaser C; Huttunen H; Tohka J;
    Neuroimage; 2015 Jan; 104():398-412. PubMed ID: 25312773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Natural Language Processing Model for COVID-19 Detection Based on Dutch General Practice Electronic Health Records by Using Bidirectional Encoder Representations From Transformers: Development and Validation Study.
    Homburg M; Meijer E; Berends M; Kupers T; Olde Hartman T; Muris J; de Schepper E; Velek P; Kuiper J; Berger M; Peters L
    J Med Internet Res; 2023 Oct; 25():e49944. PubMed ID: 37792444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting long-term progression of Alzheimer's disease using a multimodal deep learning model incorporating interaction effects.
    Wang Y; Gao R; Wei T; Johnston L; Yuan X; Zhang Y; Yu Z;
    J Transl Med; 2024 Mar; 22(1):265. PubMed ID: 38468358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.